Melissa B. Pappalardi
GlaxoSmithKline (United States)
ORCID: 0000-0001-8457-1625Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry”.
Sarah Warda, Jesper L.V. Mååg, Rohan Misra, Miguel A. Miranda-Román, Mohini R. Pachai +22 more
Rochelle L. Tiedemann, Huihui Fan, Hui Shen, Zachary Madaj, Michael T. McCabe +3 more
Kathryn Keenan, Mark Cockerill, Wendy A. Kellner, Alexandra Stowell, Christian Sherk +57 more
Abolfazl Arab, Raymond Dai, Albertas Navickas, Lisa Fish, Kristle Garcia +10 more
David A. Braun, Karl R. Clauser, Vijyendra Ramesh, Nitin H. Shirole, Joseph E. Duke-Cohan +41 more
Sarah Warda, Jesper L.V. Mååg, Rohan Misra, Miguel A. Miranda-Román, Mohini R. Pachai +20 more
Sarath Pathuri, Kristen Wong, Ren Ren, Lourdes Rueda, David T. Fosbenner +7 more